CA3091943A1 - Variants of porcine trypsin - Google Patents

Variants of porcine trypsin Download PDF

Info

Publication number
CA3091943A1
CA3091943A1 CA3091943A CA3091943A CA3091943A1 CA 3091943 A1 CA3091943 A1 CA 3091943A1 CA 3091943 A CA3091943 A CA 3091943A CA 3091943 A CA3091943 A CA 3091943A CA 3091943 A1 CA3091943 A1 CA 3091943A1
Authority
CA
Canada
Prior art keywords
seq
amino acid
variant
group
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3091943A
Other languages
English (en)
French (fr)
Inventor
Thomas Stillger
Sebastian Rissom
Claudia Feller
Andreas Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of CA3091943A1 publication Critical patent/CA3091943A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21004—Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
CA3091943A 2018-02-22 2019-02-22 Variants of porcine trypsin Pending CA3091943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18158034 2018-02-22
EP18158034.1 2018-02-22
PCT/EP2019/054400 WO2019162423A1 (en) 2018-02-22 2019-02-22 Variants of porcine trypsin

Publications (1)

Publication Number Publication Date
CA3091943A1 true CA3091943A1 (en) 2019-08-29

Family

ID=61274085

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3091943A Pending CA3091943A1 (en) 2018-02-22 2019-02-22 Variants of porcine trypsin

Country Status (13)

Country Link
US (2) US11518988B2 (enExample)
EP (1) EP3755794A1 (enExample)
JP (2) JP7432516B2 (enExample)
KR (1) KR102863070B1 (enExample)
CN (1) CN111989401A (enExample)
AU (1) AU2019225972B2 (enExample)
BR (1) BR112020016954A2 (enExample)
CA (1) CA3091943A1 (enExample)
IL (1) IL276799A (enExample)
MX (1) MX2020008766A (enExample)
MY (1) MY200951A (enExample)
SG (1) SG11202008026WA (enExample)
WO (1) WO2019162423A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019162423A1 (en) 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin
CN111676211B (zh) * 2020-05-15 2022-07-19 天津科技大学 一种抗自切和高比活力胰蛋白酶突变体
CN119552847B (zh) * 2025-01-21 2025-04-11 四川大学 链霉菌胰蛋白酶自剪切位点突变体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010022452A (ko) * 1997-07-31 2001-03-15 추후제출 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신
US7622113B2 (en) * 2003-12-08 2009-11-24 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies that bind or neutralize dengue virus
ATE517919T1 (de) * 2005-09-14 2011-08-15 Sanofi Aventis Deutschland Spaltung von insulinvorstufen durch eine trypsinvariante
BR112013009649A2 (pt) * 2010-10-29 2016-07-12 Merck Sharp & Dohme composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição
US9267114B2 (en) * 2012-11-07 2016-02-23 Southern Research Institute Flavivirus envelope protein mutations affecting virion disassembly
WO2019162423A1 (en) * 2018-02-22 2019-08-29 Sanofi-Aventis Deutschland Gmbh Variants of porcine trypsin

Also Published As

Publication number Publication date
RU2020130880A (ru) 2022-03-22
US11952602B2 (en) 2024-04-09
BR112020016954A2 (pt) 2020-12-29
JP7699196B2 (ja) 2025-06-26
MX2020008766A (es) 2020-12-07
KR20200124255A (ko) 2020-11-02
US20200377873A1 (en) 2020-12-03
RU2020130880A3 (enExample) 2022-03-22
NZ768123A (en) 2026-02-27
SG11202008026WA (en) 2020-09-29
JP2021514194A (ja) 2021-06-10
KR102863070B1 (ko) 2025-09-22
AU2019225972A1 (en) 2020-10-15
JP2024038140A (ja) 2024-03-19
US20230303994A1 (en) 2023-09-28
AU2019225972B2 (en) 2024-10-17
WO2019162423A1 (en) 2019-08-29
MY200951A (en) 2024-01-25
CN111989401A (zh) 2020-11-24
EP3755794A1 (en) 2020-12-30
IL276799A (en) 2020-10-29
US11518988B2 (en) 2022-12-06
JP7432516B2 (ja) 2024-02-16

Similar Documents

Publication Publication Date Title
US11952602B2 (en) Variants of porcine trypsin
JP6714902B2 (ja) ペプチドおよびタンパク質の発現のための方法
JP2009118849A (ja) アポリポタンパク質類似体
JP7266325B2 (ja) 蛍光タンパク質フラグメントを含む融合タンパク質およびその用途
EP4471138A1 (en) Iga protease truncation, fusion protein comprising iga protease truncation, and use thereof
KR100989413B1 (ko) 새로운 융합파트너를 이용한 재조합 단백질의 제조방법
KR101634078B1 (ko) 봉입체 형성 단백질의 제조방법
CN118302523B (zh) 包含IgA蛋白酶截短体的融合蛋白及其用途
RU2783315C2 (ru) Варианты свиного трипсина
KR100368073B1 (ko) 융합파트너를 이용한 재조합 단백질의 제조방법
CN110093336A (zh) 一种无自切的胰蛋白酶及其制备方法
CN112574286A (zh) 多肽及其应用
RU2801248C2 (ru) Гибридный белок, содержащий фрагменты флуоресцентных белков, и его применение
KR100407792B1 (ko) 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
EA052996B1 (ru) Усеченные формы iga-протеазы, слитые белки, содержащие усеченную форму iga-протеазы, и их применение
CN121605134A (zh) 包含IgA蛋白酶或其变体和聚乙二醇部分的偶联物及其用途

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240215

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250131

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250131

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250131

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250827

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251212

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251212

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20251223

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260121

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260121

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260121